Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
SLNO
#1669
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+5.51%
Variazione Mensile
-9.20%
Variazione di 6 mesi
-42.34%
Variazione Annuale
-13.27%
Chiusura Precedente
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
Volume
143
Mercati
Mercato Azionario Statunitense
Salute
SLNO
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Notizie
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Soleno Therapeutics、Jennifer FulkをCFOに任命
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug
ソレノ・セラピューティクス株、52週安値の39.42ドルを記録
Soleno Therapeutics stock hits 52-week low at 39.42 USD
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes